Light and shade of multigene panel testing for hereditary cancer: Examples from the real world
Taken together, the cases here described provide some examples of the benefits, as well as risks, involved by the use of MGPT, which may increase awareness among users and reinforce the need for establishing clear recommendations on genes to be included and management of the results.
Authors
- Giovanni Innella (ORCID: https://orcid.org/0000-0002-6909-2412)
- Daniela Turchetti (ORCID: https://orcid.org/0000-0002-6792-3921)
- Sara Miccoli (ORCID: https://orcid.org/0000-0002-8493-6230)
- Simona Ferrari
Institutions
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Tumori Journal
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1177/03008916241288078
- Citations
- 2
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.10